NightWare, Inc
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2025 | $1 M | No. 1 | Under $2 million | equity, options | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
NightWare, Inc reported revenue of $4.66 million for its most recent fiscal year (filed Mar 2025), up from $2 million the year before.
SEC Form C/A · Mar 2025
The direct cost of what it sold was $779,611, so 83% of its revenue was left after those costs.
SEC Form C/A · Mar 2025
Net loss for the same year: $283,303.
SEC Form C/A · Mar 2025
NightWare, Inc chose not to state its revenue in its newest notice of a funding round (Sep 2025).
SEC Form D · Sep 2025
The industry group it chose in its notices: Other Health Care.
SEC Form D · Sep 2025
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
No investor of NightWare, Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Matthew Tucker | Executive officer | Sep 2025 |
| Gerald Mattys | Director | Sep 2025 |
| Grady Hannah | Director | Sep 2025 |
| Matthew Tucker | Director | Sep 2025 |
| Michael Ott | Director | Sep 2025 |